LB Pharmaceuticals Inc
LBRX
$15.35
-$0.16-1.03%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Net Income | 81.63% | 68.50% | |||
| Total Depreciation and Amortization | 2,483.33% | 2,483.33% | |||
| Total Amortization of Deferred Charges | -- | -- | |||
| Total Other Non-Cash Items | -92.54% | -30.84% | |||
| Change in Net Operating Assets | -120.51% | -131.68% | |||
| Cash from Operations | 56.48% | 28.28% | |||
| Capital Expenditure | 85.37% | 87.23% | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | -63.90% | 109.61% | |||
| Cash from Investing | -63.77% | 109.57% | |||
| Total Debt Issued | -- | -- | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | -- | -- | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | -- | -- | |||
| Cash from Financing | -- | -- | |||
| Foreign Exchange rate Adjustments | -- | -- | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | 50.82% | -264.65% | |||